Sotera Health (SHC) Cash & Equivalents (2020 - 2026)

Sotera Health has reported Cash & Equivalents for 7 years, with the latest figure at $356.7 million in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 7.3% year-over-year to $356.7 million in Q2 2026; TTM through Jun 2026 was $356.7 million, a 7.3% increase from a year earlier, with the FY2025 full-year figure at $344.6 million, up 24.3% from the prior year.
• Cash & Equivalents was $356.7 million for Q2 2026 at Sotera Health, up from $314.1 million in the prior quarter.
• The five-year high for Cash & Equivalents was $647.9 million in Q1 2023, with the low at $121.4 million in Q1 2022.
• Average Cash & Equivalents over 5 years is $295.3 million, with a median of $297.8 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents jumped 433.55% in 2023, then plunged 59.7% in 2024.
• Over 5 years, Cash & Equivalents stood at $395.2 million in 2022, then retreated by 25.0% to $296.4 million in 2023, then decreased by 6.47% to $277.2 million in 2024, then grew by 24.3% to $344.6 million in 2025, then gained by 3.51% to $356.7 million in 2026.
• The last three Cash & Equivalents figures came in at $356.7 million (Q2 2026), $314.1 million (Q1 2026), and $344.6 million (Q4 2025), per Business Quant data.